Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α)

Abstract

Hypoxia-inducible factor-1α (HIF-1α) is both a potential endogenous marker of tumor hypoxia and therapeutic target, and elevated HIF-1α protein levels have been shown to be associated with increased hypoxic radiation resistance in FaDu human pharyngeal carcinoma cells in vitro. Here, we found that in FaDu xenografts, no significant HIF-1α protein accumulation was detectable by either flow cytometry or Western blot, despite the presence of hypoxic (pimonidazole-positive, radiation resistant) cells. To investigate the effect of different tumor microenvironment conditions on hypoxic HIF-1α accumulation, we performed in vitro hypoxia experiments (0.1% O 2, 24 h) with manipulation of pH (7.4 vs. 6.7), glucose (0–5.5 mM) and serum (0 or 10%) availability in FaDu and HT 1080 human fibrosarcoma cells. Hypoxic induction of HIF-1α protein was strongly dependent on glucose availability and largely abolished at 0.55 mM glucose or less in both cell lines. This glucose effect was confirmed in a hypoxia-responsive-element (HRE)/enhanced-green-fluorescent-protein (EGFP) reporter assay in transfected HT 1080 cells and possibly explains a lack of HIF-1α protein in hypoxic tumor cells.